Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
12.7M
-
Shares change
-
+73.5K
-
Total reported value, excl. options
-
$66.5M
-
Value change
-
+$430K
-
Number of buys
-
14
-
Number of sells
-
-16
-
Price
-
$5.25
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q2 2015
38 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q2 2015.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.7M shares
of 71.9M outstanding shares and own 17.63% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4.07M shares), ORBIMED ADVISORS LLC (2.67M shares), RENAISSANCE TECHNOLOGIES LLC (1.26M shares), Pine River Capital Management L.P. (1.1M shares), FIL Ltd (1.09M shares), BlackRock Fund Advisors (729K shares), FIRST MANHATTAN CO (604K shares), Zurcher Kantonalbank (Zurich Cantonalbank) (180K shares), DEUTSCHE BANK AG\ (178K shares), and Eqis Capital Management, Inc. (157K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.